Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4102509
Max Phase: Preclinical
Molecular Formula: C22H22N3Na3O12P2
Molecular Weight: 585.40
Molecule Type: Small molecule
Associated Items:
ID: ALA4102509
Max Phase: Preclinical
Molecular Formula: C22H22N3Na3O12P2
Molecular Weight: 585.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1ccn([C@@H]2O[C@H](COP(=O)([O-])O[C@@H](c3cccc(Oc4ccccc4)c3)P(=O)([O-])[O-])[C@@H](O)[C@H]2O)c(=O)n1.[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C22H25N3O12P2.3Na/c23-17-9-10-25(22(28)24-17)20-19(27)18(26)16(36-20)12-34-39(32,33)37-21(38(29,30)31)13-5-4-8-15(11-13)35-14-6-2-1-3-7-14;;;/h1-11,16,18-21,26-27H,12H2,(H,32,33)(H2,23,24,28)(H2,29,30,31);;;/q;3*+1/p-3/t16-,18-,19-,20-,21-;;;/m1.../s1
Standard InChI Key: SHDOSRBONQBOED-GYKYLPKRSA-K
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 585.40 | Molecular Weight (Monoisotopic): 585.0913 | AlogP: 1.25 | #Rotatable Bonds: 10 |
Polar Surface Area: 233.12 | Molecular Species: ACID | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.08 | CX Basic pKa: | CX LogP: 0.24 | CX LogD: -4.51 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.18 | Np Likeness Score: 0.61 |
1. Guo J, Li W, Xue W, Ye XS.. (2017) Transition State-Based Sialyltransferase Inhibitors: Mimicking Oxocarbenium Ion by Simple Amide., 60 (5): [PMID:28165727] [10.1021/acs.jmedchem.6b01644] |
2. Montgomery AP,Dobie C,Szabo R,Hallam L,Ranson M,Yu H,Skropeta D. (2020) Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I., 28 (14): [PMID:32616185] [10.1016/j.bmc.2020.115561] |
Source(1):